Antibacterial dressing for promoting scarless healing of wound surface and method for preparing the same
US-2024350702-A1 · Oct 24, 2024 · US
US10086110B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10086110-B2 |
| Application number | US-201314067120-A |
| Country | US |
| Kind code | B2 |
| Filing date | Oct 30, 2013 |
| Priority date | Oct 30, 2012 |
| Publication date | Oct 2, 2018 |
| Grant date | Oct 2, 2018 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
One aspect of the present disclosure relates to a method for forming a multipurpose membrane in vivo. One step of the method includes obtaining a blood component. Next, a vacuum assembly is operated to remove substantially all of the liquid from the blood component and thereby form a concentrated, substantially dehydrated blood component. The substantially dehydrated blood component is then formed into a non-coagulated injectable composition and administered to a wound of a subject.
Opening claim text (preview).
The following is claimed: 1. An ex vivo method for forming a multipurpose membrane, the method comprising the steps of: obtaining a volume of whole blood; contacting the volume of whole blood with an amount of thrombin and a source of calcium ions to form a coagulated whole blood component; placing the coagulated whole blood component in a wicking assembly; removing a liquid from a first surface of the coagulated whole blood component; and removing a liquid from an oppositely disposed, different second surface of the coagulated whole blood component; wherein removing liquid from the first and second surfaces results in the coagulated whole blood component having a water content of less than about 10%. 2. The method of claim 1 , wherein the coagulated whole blood component is autologous, allogeneic or xenogeneic. 3. The method of claim 1 , wherein the whole blood is subjected to ultrafiltration before contacting the whole blood with the thrombin and the source of calcium ions. 4. The method of claim 1 , wherein the step of operating a vacuum assembly further comprises the steps of: providing a vacuum assembly comprising a housing having a receiving portion in fluid communication with a suction mechanism; disposing the coagulated whole blood component in the receiving portion; and operating the suction mechanism to generate a negative pressure within the receiving portion and thereby remove substantially all of the liquid from the coagulated whole blood component. 5. The method of claim 1 , wherein the placing step further comprises pouring the coagulated white blood component into a mold. 6. The method of claim 1 , being performed at about room temperature. 7. The method of claim 1 , wherein the membrane is formed in less than about 30 minutes. 8. The method of claim 1 , further including the step of imbibing the membrane with one or more therapeutic agents. 9. The method of claim 1 , wherein the coagulated whole blood component is fully coagulated after the contacting step. 10. The method of claim 1 , wherein only operation of the wicking assembly is performed to remove the liquid from the coagulated whole blood component. 11. An ex vivo method for forming a multipurpose membrane, the method consisting of: obtaining a volume of whole blood; contacting the volume of whole blood with an amount of thrombin and a source of calcium ions to form a coagulated whole blood component; placing the coagulated whole blood component in a wicking assembly; removing a liquid from a first surface of the coagulated whole blood component; and removing a liquid from an oppositely disposed, different second surface of the coagulated whole blood component; wherein removing liquid from the first and second surfaces results in the coagulated whole blood component having a water content of less than about 10%.
for nerve reconstruction · CPC title
Fibrin; Fibrinogen · CPC title
Ingredients of undetermined constitution or reaction products thereof · CPC title
Ingredients of undetermined constitution or reaction products thereof · CPC title
Blood, e.g. platelet-rich plasma · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.